Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to study content or page functionality.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page footer.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added and notices for Revision: v3.4.1 and the government funding lapse were removed.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision label to v3.4.1. The previous revision label v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.